Abstract
US demand to grow 4.5% annually through 2013
The Freedonia Group projects that total demand for infection prevention
products and services will increase 4.5 percent annually through 2013. Growth
will partially reflect the impact of new government legislation and changing
health insurance reimbursement policies aimed at reducing the incidence of
health care-acquired infections (HAIs). Gains will also be driven by efforts
to reduce the incidence of HAIs in health care and life science
establishments, prompting upgrades to standards involving patient and staff
hygiene and protection, facility cleaning and disinfection, device and
instrument sterilization, and medical waste collection and disposal.
Safety-enhanced devices to offer best opportunities
Safety-enhanced devices for IV and injectable drug delivery and in vivo fluid
withdrawal, along with high quality apparel, textiles and disinfectants for
surgical procedures, will remain the top selling groups of infection
prevention products. An increasing percentage of the syringes, catheters, IV
administration sets, blood collection supplies and other disposable sharp
instruments employed by the medical community will incorporate safety
components designed to prevent accidental needlesticks and associated
infections after use. Spurred by a rising volume of inpatient, outpatient,
nursing home care and home health care episodes, demand for safetyenhanced
medical devices is projected to rise 6.2 percent annually through 2013.
The elevated risk of transmitting air- and blood-borne infections during
surgery will foster the expanding use of high barrier drapes, gowns and gloves
and high level disinfectants in hospital and ambulatory operating rooms. In
addition, upgraded infection prevention standards will encourage the immediate
changing of apparel and textiles that are heavily splattered with blood or
other body fluids during surgical procedures. Based on upward trends in the
volume and mix of operations, the total market for surgical infection
prevention products is forecast to grow 3.6 percent annually through 2013.
Cost containment pressures and advances in less invasive surgical techniques
will moderate faster growth.
Personal, surface and instrument disinfectants consumed by health care and
life science facilities will grow 4.0 percent annually through 2013. Pressures
to adopt stricter patient and staff hygiene and facility cleaning and
disinfection practices will foster gains in health care establishments.
Disinfectant use in the life sciences sector will expand as production systems
and research and diagnostic investigations become increasingly complex and
more vulnerable to microbial contamination.
Health care and life science markets for sterilization supplies, equipment and
services will expand as medical providers and producers adopt stricter
protocols to ensure the safety of new and reprocessed products. Stepped up
efforts to prevent the transmission of pathogenic microorganisms to and from
staff personnel will promote the rising use of examination and laboratory
gloves and other protective apparel in the health care and life science
sectors. However, multiple source availability and downward pricing pressures
will moderate overall growth opportunities for these products. Lastly, the
widespread upgrading of medical and life science infection prevention
standards, coupled with continuing restrictions on onsite incineration, will
create above average growth opportunities for medical waste disposal supplies,
equipment and services.
Study coverage
Infection Prevention Products & Services is a new Freedonia industry study,
presents US historical demand data (1998, 2003 and 2008) plus forecasts for
2013 and 2018 by product and market. The study also considers market
environment factors, evaluates company market share data and profiles 26
industry competitors.
| 
View Cart
